Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
about
Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@en
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@nl
type
label
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@en
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@nl
prefLabel
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@en
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@nl
P2093
P2860
P1476
Rosuvastatin may modulate insu ...... ect in insulin-resistant mice.
@en
P2093
Hangyuan Guo
Jufang Chi
Longbin Liu
Weiliang Tang
Xiaoya Zhai
P2860
P304
P356
10.1007/S10557-012-6406-0
P577
2012-10-01T00:00:00Z